Stay updated on Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    No significant changes to core content were detected; only minor formatting adjustments observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:43:09.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Major update adds a government operations notice and NIH Clinical Center status with a v3.2.0 release; removes a specific resource (Small cell lung carcinoma) from the GARD list and drops the v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T04:22:54.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Updated the page version from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.0%
    Check dated 2025-09-28T23:39:18.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Updated from v3.0.1 to v3.0.2, indicating a new patch release; the Back to Top link was removed as a minor UI change. No other substantive changes to core content were detected.
    Difference
    0.1%
    Check dated 2025-09-14T09:59:12.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T07:55:28.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically highlighting Washington D.C. and the addition of various medical terms related to proteins and antibodies, while removing some previous location and cancer-related topics.
    Difference
    2%
    Check dated 2025-08-31T01:05:43.000Z thumbnail image

Stay in the know with updates to Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page.